News

CATTI and bioMérieux Canada are joining forces to support the development of a qualified workforce in advanced therapies.

December 7, 2023 (Montreal, Canada) – CATTI and bioMérieux Canada are combining their respective  strengths to enhance the training of the workforce in advanced therapies and the production of quality  control solutions (for the pharmaceutical industries). 

For more details follow the link

 

CATTI et bioMérieux Canada unissent leurs forces pour soutenir le développement d'une main-d'œuvre qualifiée en thérapies avancées.

7 décembre 2023 (Montréal, Canada) – CATTI et bioMérieux Canada unissent leurs forces respectives pour  développer la formation de la main-d’œuvre en thérapies avancées et la production de fourniture de  solutions de contrôle qualité (pour les industries pharmaceutiques). 

Suivez le lien pour plus d’information

CATTI and Cell and Gene Therapy Catapult partner to establish international best practice standards in advanced therapies manufacturing training

October 12, 2023 (London, United Kingdoms), (Montreal, Canada) — The Canadian Advanced Therapies Training Institute (CATTI) and Cell and Gene Therapy Catapult (CGT Catapult) have entered into an agreement to advance regenerative medicine, including cell and gene therapy training locally and globally. Both institutions have agreed to the development of joint activities to address issues of mutual interest. The ultimate goal is to establish international best practice standards in advanced therapies manufacturing training.

CATTI opens a cell and gene therapy training centre of excellence at the University of Guelph
GUELPH, ONMay 15, 2023 /CNW/ – The Canadian Advanced Therapies Training Institute (CATTI) Inc. has launched its first in-person training site at the University of Guelph through a partnership with OmniaBio Inc., CCRM and the university. The training program, to begin in summer 2023, will cater to recent post-secondary graduates, industry professionals and companies growing their roster of clean room manufacturing staff. The fast growth of cell and gene therapies (CGTs) has made it a challenge for the global industry to keep up with talent requirements. This new CGT technical training site will begin to address the industry’s critical training needs and represents the first stage of a larger, multi-site training strategy for CATTI. Read full press release.